Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported its Q1 earnings results on Wednesday, February 2, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Also check out: Insiders Buying Pixelworks And 4 Other Penny Stocks
Earnings
Arrowhead Pharmaceuticals missed estimated earnings by 33.33%, reporting an EPS of $-0.6 versus an estimate of $-0.45, which surprised analysts.
Revenue was up $6.14 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.51, which was followed by a 2.32% increase in the share price the next day.
Here’s a look at Arrowhead Pharmaceuticals’s past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.10 | -0.20 | -0.13 | 0.17 |
| EPS Actual | -0.61 | -0.29 | -0.26 | -0.20 |
| Revenue Estimate | 56.77M | 37.52M | 37.70M | 86.69M |
| Revenue Actual | 38.28M | 45.89M | 32.81M | 21.30M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
